Literature DB >> 2578469

Prophylaxis of deep-vein thrombosis after total hip replacement. Dextran and external pneumatic compression compared with 1.2 or 0.3 gram of aspirin daily.

W H Harris, C A Athanasoulis, A C Waltman, E W Salzman.   

Abstract

The efficacy of three prophylactic regimens against deep venous thrombosis was assessed in 135 patients who were more than thirty-nine years old and had a total hip replacement. The three regimens were 1.2 grams of aspirin daily, 0.3 gram of aspirin daily, and external pneumatic compression of the calf and thigh combined with low-molecular-weight dextran that was given for three days, beginning during the operation. In all patients, detection of fresh thrombi was by the fibrinogen-uptake test, cuff-impedance plethysmography, and venography. New venous thromboses developed in twenty-nine of forty-eight patients receiving 1.2 grams of aspirin and in twenty-six of forty-three receiving 0.3 gram of aspirin, indicating that the lower dose of aspirin had no advantage. Thromboembolic disease developed in only nine of forty-four patients who were on the regimen of external compression and dextran. This combination was significantly better than aspirin in both men and women. Dextran appeared to be associated with excessive bleeding when given in doses of more than 500 milliliters during the operation, but not when given in less than that amount.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578469

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  14 in total

Review 1.  Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  John W Eikelboom; Jack Hirsh; Frederick A Spencer; Trevor P Baglin; Jeffrey I Weitz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

Review 2.  Venous thromboembolism: epidemiology, diagnosis, prevention.

Authors:  D M Becker
Journal:  J Gen Intern Med       Date:  1986 Nov-Dec       Impact factor: 5.128

Review 3.  Preoperative evaluation: the assessment and management of surgical risk.

Authors:  K Kroenke
Journal:  J Gen Intern Med       Date:  1987 Jul-Aug       Impact factor: 5.128

4.  DVT prophylaxis in total hip replacement.

Authors:  T G DeLoughery
Journal:  J Gen Intern Med       Date:  1993-11       Impact factor: 5.128

5.  Effect of optimization of hemodynamics on fibrinolytic activity and antithrombotic efficacy of external pneumatic calf compression.

Authors:  E W Salzman; G P McManama; A H Shapiro; L K Robertson; A S Donovan; H W Blume; J Sweeney; R D Kamm; M C Johnson; P M Black
Journal:  Ann Surg       Date:  1987-11       Impact factor: 12.969

Review 6.  The pathogenesis and prevention of thromboembolic complications in patients undergoing total hip replacement.

Authors:  D K Potyk; H J Tabbarah
Journal:  J Gen Intern Med       Date:  1993-04       Impact factor: 5.128

7.  Prevention of deep vein thrombosis after hip replacement: randomised comparison between unfractionated heparin and low molecular weight heparin.

Authors:  P F Leyvraz; F Bachmann; J Hoek; H R Büller; M Postel; M Samama; M D Vandenbroek
Journal:  BMJ       Date:  1991-09-07

8.  Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration.

Authors: 
Journal:  BMJ       Date:  1994-01-22

Review 9.  Aspirin in cardiovascular disease.

Authors:  I A Reilly; G A FitzGerald
Journal:  Drugs       Date:  1988-02       Impact factor: 9.546

10.  Results of adjusted-dose heparin for thromboembolism prophylaxis in knee replacement compared to those found for its use in hip fracture surgery and elective hip replacement.

Authors:  David Yen; William Weiss
Journal:  Iowa Orthop J       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.